Absence of latitudinal gradient in oligoclonal bands prevalence in Argentina.

Clinically isolated syndrome Epidemiology Latitudinal gradient Multiple sclerosis Oligoclonal bands Radiologically isolated syndrome

Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 22 09 2020
revised: 06 10 2020
accepted: 12 10 2020
pubmed: 11 12 2020
medline: 15 5 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

Like MS prevalence, oligoclonal bands (OCB) frequency seems to follow a latitudinal gradient. Argentina is extensive, latitude-wise, and previous studies have not found an MS prevalence latitudinal gradient. Our aim is to describe OCB prevalence in MS, clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) patients included in the Argentinean MS and NMOSD registry (RelevarEM) and to investigate if it follows a latitudinal gradient. For each province, an average latitude was calculated, and OCB frequency was investigated. Multivariate logistical regression analysis and linear correlation were performed. Statistical analysis was repeated after excluding patients from centers using isoelectric focusing (IEF) in less than 95% of patients (CwIEF<95). We included 2866 patients. OCB where positive in 73.9% of patients. No association or correlation were found between OCB and latitude of residence, even after excluding patients from (CwIEF<95). OCB positivity does not follow a latitudinal gradient in Argentina. Also, OCB positivity is lower than described in other world regions.

Sections du résumé

BACKGROUND BACKGROUND
Like MS prevalence, oligoclonal bands (OCB) frequency seems to follow a latitudinal gradient. Argentina is extensive, latitude-wise, and previous studies have not found an MS prevalence latitudinal gradient. Our aim is to describe OCB prevalence in MS, clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) patients included in the Argentinean MS and NMOSD registry (RelevarEM) and to investigate if it follows a latitudinal gradient.
METHODS METHODS
For each province, an average latitude was calculated, and OCB frequency was investigated. Multivariate logistical regression analysis and linear correlation were performed. Statistical analysis was repeated after excluding patients from centers using isoelectric focusing (IEF) in less than 95% of patients (CwIEF<95).
RESULTS RESULTS
We included 2866 patients. OCB where positive in 73.9% of patients. No association or correlation were found between OCB and latitude of residence, even after excluding patients from (CwIEF<95).
CONCLUSION CONCLUSIONS
OCB positivity does not follow a latitudinal gradient in Argentina. Also, OCB positivity is lower than described in other world regions.

Identifiants

pubmed: 33296978
pii: S2211-0348(20)30656-8
doi: 10.1016/j.msard.2020.102582
pii:
doi:

Substances chimiques

Oligoclonal Bands 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

102582

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Laura Negrotto (L)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina. Electronic address: lnegrotto@fleni.org.ar.

Mariano Marrodan (M)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina.

Marcela P Fiol (MP)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina.

María I Gaitán (MI)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina.

María C Ysrraelit (MC)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina.

Carlos Vrech (C)

Departamento de Enfermedades desmielinizantes - Sanatorio Allende, Córdoba, Argentina.

Agustín Pappolla (A)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Jimena Miguez (J)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Liliana Patrucco (L)

Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Edgardo Cristiano (E)

Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina.

Juan I Rojas (JI)

Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina; Servicio de Neurología, Hospital Universitario de CEMIC, CABA, Argentina.

Adriana Carrá (A)

Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina; Instituto de Neurociencias - Fundación Favaloro/INECO, CABA, Argentina.

Aníbal Chertcoff (A)

Instituto de Neurociencias - Fundación Favaloro/INECO, CABA, Argentina.

Judith Steinberg (J)

Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina.

Alejandra D Martinez (AD)

Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina.

María C Curbelo (MC)

Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina.

Leila Cohen (L)

Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, CABA, Argentina.

Ricardo Alonso (R)

Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, CABA, Argentina; Sanatorio Güemes, CABA, Argentina.

Orlando Garcea (O)

Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, CABA, Argentina.

Cecilia Pita (C)

Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, CABA, Argentina.

Berenice Silva (B)

Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, CABA, Argentina.

Geraldine Luetic (G)

Instituto de Neurociencias de Rosario, Rosario, Santa Fe, Argentina.

Norma Deri (N)

Centro de Investigaciones Diabaid, CABA, Argentina.

María E Balbuena (ME)

Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina.

Verónica Tkachuk (V)

Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina.

Edgar Carnero Contentti (E)

Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, CABA, Argentina.

Pablo A Lopez (PA)

Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, CABA, Argentina.

Juan Pablo Pettinicchi (JP)

Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, CABA, Argentina.

Alejandro Caride (A)

Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, CABA, Argentina.

Marcos Burgos (M)

Servicio de Neurología - Hospital San Bernardo, Salta, Argentina.

Felisa Leguizamon (F)

Hospital de Agudos, Dr. Teodoro Álvarez, CABA, Argentina.

Eduardo Knorre (E)

Hospital de Agudos, Dr. Teodoro Álvarez, CABA, Argentina.

Raúl Piedrabuena (R)

Clínica Universitaria Reina Fabiola, Córdoba, Argentina; Instituto Lennox, Córdoba, Argentina.

Andrés Barboza (A)

Hospital Central de Mendoza, Mendoza, Argentina.

Susana Liwacki (S)

Clínica Universitaria Reina Fabiola, Córdoba, Argentina; Servicio de Neurología - Hospital Córdoba, Córdoba, Argentina.

Pedro Nofal (P)

Hospital de Clínicas Nuestra Señora del Carmen, San Miguel de Tucumán, Tucumán, Argentina.

Gabriel Volman (G)

Hospital presidente Perón de Avellaneda, Buenos Aires, Argentina.

Amelia Alves Pinheiro (A)

Hospital San Martín, Paraná, Entre Ríos, Argentina.

Javier Hryb (J)

Servicio de Neurología - Hospital Carlos G. Durand, CABA, Argentina.

Darío Tavolini (D)

INECO Neurociencias Oroño, Rosario, Santa Fe, Argentina.

Patricio Blaya (P)

Neurocomp, Trelew, Chubut, Argentina.

Luciano Recchia (L)

Servicio de Neurología. Hospital Central Mendoza, Argentina.

Carolina Mainella (C)

Hospital Español de Rosario, Santa Fe, Argentina.

Matías Kohler (M)

Fundación Sinapsis Santa Rosa, La Pampa, Argentina.

Eduardo Kohler (E)

Fundación Sinapsis Santa Rosa, La Pampa, Argentina.

Jorge Blanche (J)

IRNEC (Instituto Regional de Neurociencias), San Miguel de Tucumán, Argentina.

Santiago Tizio (S)

Hospital Español de la Plata, Buenos Aires, Argentina.

María L Saladino (ML)

INEBA, Institute of Neuroscience Buenos Aires, CABA, Argentina.

Fernando Caceres (F)

INEBA, Institute of Neuroscience Buenos Aires, CABA, Argentina.

Nora Fernández Liguori (N)

Sanatorio Güemes, CABA, Argentina; Hospital Enrique Tornú, CABA, Argentina.

Luciana Lazaro (L)

Sanatorio Güemes, CABA, Argentina.

Gisela Zanga (G)

Unidad asistencial César Milstein, CABA, Argentina.

Marcela Parada Marcilla (M)

SIENES, Centro de Neurorehabilitación de Buenos Aires, Argentina.

María E Fracaro (ME)

Clínica el Castaño, San Juan, Argentina.

Fátima Pagani Cassara (F)

Instituto de Neurociencias - Fundación Favaloro/INECO, CABA, Argentina.

Guido Vazquez (G)

Instituto de Neurociencias - Fundación Favaloro/INECO, CABA, Argentina.

Vladimiro Sinay (V)

Instituto de Neurociencias - Fundación Favaloro/INECO, CABA, Argentina.

Gustavo Sgrilli (G)

Axis Neurociencias, Bahía Blanca, Buenos Aires, Argentina.

Pablo Divi (P)

RIAPEM (Red Integral Asistencial al Paciente con Esclerosis Múltiple), Santiago del Estero, Argentina.

Miguel Jacobo (M)

RIAPEM (Red Integral Asistencial al Paciente con Esclerosis Múltiple), Santiago del Estero, Argentina.

Emanuel Silva (E)

Predigma - Centro de Medicina Preventiva, Posadas, Misiones, Argentina.

Edgardo Reich (E)

Servicio de Neurología, Hospital Municipal Dr. Julio Méndez, CABA, Argentina.

Lorena M Cabrera (LM)

Servicio de Neurología - Hospital Militar Central, CABA, Argentina; Hospital Militar Campo de Mayo, CABA, Argentina.

María L Menichini (ML)

Sanatorio Británico, Rosario, Santa Fe, Argentina.

Mariano Coppola (M)

Servicio de Neurología, Hospital Ramón Santamarina, Tandil, Buenos Aires, Argentina.

Iván Martos (I)

Clínica San Jorge, Ushuaia, Tierra del fuego, Argentina.

Juan Pablo Viglione (JP)

Clínica Regional del Sud, Río Cuarto, Córdoba, Argentina.

Gustavo Jose (G)

Sección de enfermedades desmielinizantes, Servicio de Neurología, Hospital Padilla, Tucumán, Argentina.

Santiago Bestoso (S)

Servicio Neurología - Hospital Escuela José F. de San Martín Corrientes, Corrientes, Argentina.

Rubén Manzi (R)

Sanatorio Pasteur, Catamarca, Argentina.

Diego Giunta (D)

Servicio de clínica médica, Hospital Italiano de Buenos Aires, CABA, Argentina.

María L Doldan (ML)

Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina.

Marina Alonso Serena (M)

Servicio de clínica médica, Hospital Italiano de Buenos Aires, CABA, Argentina.

Jorge Correale (J)

Neuroimmunology Unit - FLENI, Montañeses 2325, CABA, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH